Jazz Pharmaceuticals has reached an agreement to buy Nasdaq-listed Chimerix for around $935 million, adding a brain cancer drug that is heading for an FDA verdict in the summer. The Irish and US ...
The Elder Scrolls's lore is so complicated that picking out the most powerful characters can be difficult. However, we are ...
Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 K27M mutations, a rare brain cancer mainly affecting young people. The ...
"I sit here just knowing that my babies are a part of me on a cellular level and that healed something in me when I heard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results